A novel oxygen carrier “YQ23” suppresses the liver tumor metastasis by decreasing circulating endothelial progenitor cells and regulatory T cells

BACKGROUND: Surgical therapies are the first-line treatments for hepatocellular carcinoma (HCC) patients. However, the high incidence of tumor metastasis after liver surgery remains a severe problem. We aim to investigate the roles and the underlying mechanism of YQ23, stabilized non-polymeric diasp...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Li, Chang Xian, Wong, Bing L, Ling, Chang Chun, Ma, Yuen Yuen, Shao, Yan, Geng, Wei, Qi, Xiang, Lau, Sze Hang, Kwok, Sui Yi, Wei, Na, Tzang, Fei Chuen, Ng, Kevin TP, Liu, Xiao Bing, Lo, Chung Mau, Man, Kwan
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4006450/
https://ncbi.nlm.nih.gov/pubmed/24766798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-293
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items